Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher	pref label
tabling member	label

Search

418446

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:18
	ddp modified	17/09/2015 10:39:01
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Eyesight: Testing
	house id	1
	identifier	10017
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	17/09/2015 10:07:37
	question text	To ask the Secretary of State for Health, how many people were diagnosed with (a) a brain tumour and (b) other conditions as a result of symptoms noticed during examinations by opticians in the last 12 months.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10017
	type	WrittenParliamentaryQuestion
	uin	10017
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418447

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:18
	ddp modified	21/09/2015 10:36:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Statins
	house id	1
	identifier	10020
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	21/09/2015 10:04:02
	question text	To ask the Secretary of State for Health, if he will take steps to ensure patients prescribed statins can make a choice on what type of statins they receive.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10020
	type	WrittenParliamentaryQuestion
	uin	10020
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418448

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:19
	ddp modified	21/09/2015 10:37:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Smoking
	house id	1
	identifier	10021
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	21/09/2015 10:05:51
	question text	To ask the Secretary of State for Health, what information his Department holds on how many people of what age ranges gave up smoking in each of the last five years.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10021
	type	WrittenParliamentaryQuestion
	uin	10021
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418449

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:20
	ddp modified	17/09/2015 16:41:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Alzheimer's Disease: Dental Health
	house id	1
	identifier	10023
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	17/09/2015 16:09:59
	question text	To ask the Secretary of State for Health, if he will commission a study to investigate potential links between dental treatment and Alzheimer's disease.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10023
	type	WrittenParliamentaryQuestion
	uin	10023
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418450

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:21
	ddp modified	16/09/2015 15:47:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	identifier	10022
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:15:57
	question text	To ask the Secretary of State for Health, what criteria NICE has set for new dementia treatments to be recommended for provision by the NHS.
	session	2015/16
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2015/16 10022
	type	WrittenParliamentaryQuestion
	uin	10022
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

418451

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:23
	ddp modified	16/09/2015 15:54:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10091
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:22:40
	question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the decision by NHS England announced on 4 September 2015 to remove (a) the pancreatic cancer drug Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10091
	type	WrittenParliamentaryQuestion
	uin	10091
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418452

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:23
	ddp modified	16/09/2015 15:55:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10092
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:23:43
	question text	To ask the Secretary of State for Health, what mechanisms there are for appeal against NHS England's decision announced on 4 September 2015 to remove (a) Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs; and if he will make a statement.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10092
	type	WrittenParliamentaryQuestion
	uin	10092
	version	2
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418453

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:24
	ddp modified	16/09/2015 15:57:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	identifier	10093
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:25:30
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect on cancer clinical trials of NHS England's decision announced on 4 September 2015 to remove (a) Abraxane and (b) 22 other drugs and indications from the Cancer Drugs Fund list of approved drugs; and if he will make a statement.
	session	2015/16
	session number	1
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	title	House of Commons Tabled Parliamentary Question 2015/16 10093
	type	WrittenParliamentaryQuestion
	uin	10093
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	4056 label Biography information for Nic Dakin
	publisher	25259 pref label House of Commons
	tabling member	4056 label Biography information for Nic Dakin

418454

	human indexable
	published
	registered interest
	answer date	15/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:25
	ddp modified	21/09/2015 10:32:03
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ehlers-Danlos Syndrome
	house id	1
	identifier	9988
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	21/09/2015 10:00:16
	question text	To ask the Secretary of State for Health, what recent discussions his Department has had with health bodies on ensuring timely treatment for sufferers of Ehlers-Danlos syndrome.
	session	2015/16
	session number	1
	tabling member constituency	Bury North
	tabling member printed	Mr David Nuttall
	title	House of Commons Tabled Parliamentary Question 2015/16 9988
	type	WrittenParliamentaryQuestion
	uin	9988
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4140 label Biography information for Mr David Nuttall
	publisher	25259 pref label House of Commons
	tabling member	4140 label Biography information for Mr David Nuttall

418455

	human indexable
	published
	registered interest
	answer date	16/09/2015
	date	11/09/2015
	date tabled	11/09/2015
	ddp created	11/09/2015 18:41:26
	ddp modified	16/09/2015 15:49:02
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer
	house id	1
	identifier	9996
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/09/2015 15:17:51
	question text	To ask the Secretary of State for Health, when he expects the final results of the National Institute for Health Research's ProtecT trials for prostate cancer testing to be published; and if he will make a statement.
	session	2015/16
	session number	1
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	title	House of Commons Tabled Parliamentary Question 2015/16 9996
	type	WrittenParliamentaryQuestion
	uin	9996
	version	1
	written parliamentary question type	NamedDay
	answer	answer is ministerial correction
	creator	1409 label Biography information for Mr Gregory Campbell
	publisher	25259 pref label House of Commons
	tabling member	1409 label Biography information for Mr Gregory Campbell